Collaborative Studies and Reporting Back
Date: Saturday 14 May
Time: 08:30 – 16:00
| Time | Event |
|---|---|
| 09:00 – 12:00 | Patient Advocacy and Education – UK, Spain, Germany, USA |
| 08:30 – 10:30 | Reporting Back Session |
| 08:30 – 08:45 | Registries – Pål Møller |
| 08:45 – 09:00 | IMRC – Mark Jenkins |
| 09:00 – 09:15 | MMR European Group – Moni Morak, Elke Holinski, Gabriel Capella |
| 09:15 – 09:30 | Surgery and Endoscopy – Gabriel Moeslein, others |
| 09:30 – 09:45 | Chemoprevention for Polyposis Syndromes – Pat Lynch, others |
| 09:45 – 10:00 | VIC: Variant Interpretation Committee – Maurizio Genaurdi, John-Paul Plazzer |
| 10:00 – 10:15 | Chemoprevention LS and Immunotherapy – Magnus V Knebel-Doeberitz, John Burn |
| 10:15 – 10:30 | To be confirmed |
| 10:30 – 11:00 | Coffee Break |
| 11:00 – 12:30 | EHTG Open and New Collaborative Studies |
| 11:00 – 11:15 | Renal Cell Carcinoma in Lynch Syndrome: a Preliminary Report from a Mallorca Group Collaborative Study – Maurizio Genuardi |
| 11:15 – 11:30 | Role of Genetic Modifiers in Disease Risk – Lynch Syndrome – Rodney Scott, Bente Talseth-Palmer |
| 11:30 – 11:45 | IMRC – Mark Jenkins |
| 11:45 – 12:00 | PLSD: New Goals/Call for Additional Data – Pål Møller |
| 12:00 – 12:30 | Reporting Back from Patient Advocacy and Education |
| 12:30 – 13:15 | Lunch |
| 13:15 – 16:00 | Former Mallorca Group Meeting |